Skip to main content
. 2015 Aug;56(4):334–343. doi: 10.3325/cmj.2015.56.334

Figure 3.

Figure 3

Baseline red blood cell distribution width (RDW) in patients with diffuse large B-cell lymphoma (DLBCL) (N = 80) (A) according to the treatment outcome and (B) according to response to the treatment; (C) in patients with DLBCL treated with immunochemotherapy according to the treatment outcome (N = 77).